COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,681 Articles (22,913 medRxiv, 8,768 bioRxiv)

Most recent first Previous |  Page 2250: Articles 22491-22500  | Next

COVID-19 in Portugal: predictability ofhospitalization, ICU and respiratory-assistance needs
Patricio, A., Costa, R. S., Henriques, R.
10.1101/2020.09.29.20203141 — Posted: 2020-09-29
SARS-CoV-2 D614G Variant Exhibits Enhanced Replication ex vivo and Earlier Transmission in vivo
Hou, Y. J., Chiba, S., Halfmann, P., Ehre, C., Kuroda, M., Dinnon, K. H., Leist, S. R., Schäfer, A., Nakajima, N., Takahashi, K., Lee, R. E., Mascenik, T. M., Edwards, C. E., Tse, L. V., Boucher, R. C., Randell, S. H., Suzuki, T., Gralinski, L. E., Kawaoka, Y., Baric, R. S.
10.1101/2020.09.28.317685 — Posted: 2020-09-29
Susceptibility of midge and mosquito vectors to SARS-CoV-2 by natural route of infection
Balaraman, V., Drolet, B. S., Gaudreault, N. N., Wilson, W. C., Owens, J., Bold, D., Swanson, D. A., Jasperson, D. C., Noronha, L. E., Richt, J. A., Mitzel, D.
10.1101/2020.09.29.317289 — Posted: 2020-09-29 Discussion: Onsite
Prime-boost vaccination of mice and Rhesus macaques with two novel adenovirus vectored COVID-19 vaccine candidates
Luo, S., Zhang, P., Li, B., Yang, C., Liang, C., Wang, Q., Zhang, L., Tang, X., Li, J., Hou, S., Zeng, J., Fu, Y., Allain, J.-P., Li, T., Zhang, Y., Li, C.
10.1101/2020.09.28.311480 — Posted: 2020-09-29
Causal Analysis of Health Interventions and Environments for Influencing the Spread of COVID-19 in the United States of America
Li, z., Xu, T., Zhang, K., Deng, H.-W., Boerwinkle, E., Xiong, M.
10.1101/2020.09.29.20203505 — Posted: 2020-09-29
Predictive Modelling of COVID-19 New Cases in Algeria using An Extreme Learning Machines (ELM)
Djeddou, M., A. Hameed, I., Nejatian, A., Loukam, I.
10.1101/2020.09.28.20203299 — Posted: 2020-09-29
Analysis of the COVID-19 pandemic in Bavaria: adjusting for misclassification
Guenther, F., Bender, A., Höhle, M., Wildner, M., Küchenhoff, H.
10.1101/2020.09.29.20203877 — Posted: 2020-09-29
Brief communication: A meta-analysis of randomized trials of hydroxychloroquine for the prevention of COVID-19
Garcia-Albeniz, X., Del Amo, J., Polo, R., Morales Asencio, J. M., Hernan, M. A.
10.1101/2020.09.29.20203869 — Posted: 2020-09-29 Discussion: Onsite | Offsite
De Novo Discovery of High Affinity Peptide Binders for the SARS-CoV-2 Spike Protein
Pomplun, S., Jbara, M., Quartararo, A. J., Zhang, G., Brown, J. S., Lee, Y.-C., Ye, X., Hanna, S., Pentelute, B. L.
10.1101/2020.09.29.317131 — Posted: 2020-09-29
Changes to the sebum lipidome upon COVID-19 infection observed via non-invasive and rapid sampling from the skin
Spick, M. P., Longman, K., Frampas, C., Costa, C., Dunn-Walters, D., Stewart, A., Wilde, M., Greener, D., Evetts, G., Trivedi, D. K., Barran, P., Pitt, A., Bailey, M.
10.1101/2020.09.29.20203745 — Posted: 2020-09-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).